Official title and information are available only for Plus and Premium subscribers.
Patent Pending Rhamnolipids have long been reported to have antimicrobial properties.[19] They have been shown to have activity against a range of bacteria including Serratia marcescens, Klebsiella pneumoniae, Staphylococcus aureus and Bacillus subtilis with minimum inhibitory concentrations (MICs) ranging from 0.5 µg/mL to 32 µg/mL. Activity against several fungi such as Fusarium solani and Penicillium funiculosum have also been observed with MICs of 75 µg/mL and 16 µg/mL respectively.[20] Rhamnolipids have been suggested as antimicrobials able to remove Bordetella bronchiseptica biofilms.